<TEXT>&#2;<DATELINE>2018-08-07</DATELINE><TITLE>A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice</TITLE><BODY>&#3;</BODY></TEXT>